Results 271 to 280 of about 145,099 (296)
Some of the next articles are maybe not open access.
Immunophenotyping of Chronic Lymphocytic Leukemia
Clinical Laboratory, 2017Chronic Lymphocytic Leukemia (CLL) is one of the most common diagnoses made by flow cytometry laboratories. There is no consensus on which markers need to be used in flow cytometry for accurate immunophenotyping. Herein, we investigated the role of markers used in flow cytometry in the distinction between CLL and MCL.A total 339 recently diagnosed B ...
Falay, Mesude, Ozet, GÜLSÜM
openaire +3 more sources
“Smouldering” Chronic Lymphocytic Leukemia
Leukemia & Lymphoma, 1991Although clinical staging systems are useful to assess the prognosis of chronic lymphocyctic leukemia (CLL), for the large majority (up to 60%) of patients in early clinical stage no system is able to predict those who will progress ("active" disease) and those who will remain at the same stage ("smouldering" disease).
E, Montserrat +4 more
openaire +2 more sources
The American Journal of the Medical Sciences, 1994
P B, Caguioa, S, Tansan, R P, McCaffrey
openaire +2 more sources
P B, Caguioa, S, Tansan, R P, McCaffrey
openaire +2 more sources
Prognostic factors in chronic lymphocytic leukemia—what do we need to know?
Nature Reviews Clinical Oncology, 2010Paula Cramer, Michael Hallek
exaly
Chemoimmunotherapy of chronic lymphocytic leukemia
Nature Reviews Clinical Oncology, 2010Constantine S Tam
exaly
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine, 2014Bruce D Cheson +2 more
exaly
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
New England Journal of Medicine, 2000Hartmut Döhner +2 more
exaly
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine, 2013Ian W Flinn +2 more
exaly